Nothing Special   »   [go: up one dir, main page]

Goezinne et al., 2008 - Google Patents

Low redetachment rate due to encircling scleral buckle in giant retinal tears treated with vitrectomy and silicone oil

Goezinne et al., 2008

View PDF
Document ID
548610887193381196
Author
Goezinne F
La Heij E
Berendschot T
Gast S
Liem A
Lundqvist I
Hendrikse F
Publication year
Publication venue
Retina

External Links

Snippet

Background: The goal of this study was to identify risk factors for redetachment and to assess long-term anatomic and functional results of pars plana vitrectomy (PPV) for retinal detachment associated with giant retinal tears (GRT). Subjects and Methods: In a …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/102—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for optical coherence tomography [OCT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Method or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery

Similar Documents

Publication Publication Date Title
Goezinne et al. Low redetachment rate due to encircling scleral buckle in giant retinal tears treated with vitrectomy and silicone oil
Casini et al. Inverted internal limiting membrane flap technique for macular hole surgery without extra manipulation of the flap
Lai et al. Lamellar hole-associated epiretinal proliferation in lamellar macular hole and full-thickness macular hole in high myopia
Miller et al. Primary repair of retinal detachment with 25-gauge pars plana vitrectomy
Chen et al. Pediatric rhegmatogenous retinal detachment in Taiwan
Luk et al. Presence of crystalline lens as a protective factor for the late development of open angle glaucoma after vitrectomy
Ahn et al. Effect of intravitreal triamcinolone injection during vitrectomy for idiopathic epiretinal membrane
Wu et al. Surgical outcomes in eyes with extremely high myopia for macular hole without retinal detachment
Shroff et al. Bimanual microincision vitreous surgery for severe proliferative diabetic retinopathy: outcome in more than 300 eyes
Cunningham et al. Proliferative vitreoretinopathy may be a risk factor in combined macular hole retinal detachment cases
Álvarez et al. Anatomical and visual outcomes of inverted internal limiting membrane flap technique versus internal limiting membrane peeling in myopic macular hole without retinal detachment: a preliminary retrospective study
Jeng et al. Incidence of steroid-induced ocular hypertension after vitreoretinal surgery with difluprednate versus prednisolone acetate
Schrey et al. Incidence of rhegmatogenous retinal detachment after vitrectomy in eyes of diabetic patients
Chuang et al. Vitrectomy and panretinal photocoagulation reduces the occurrence of neovascular glaucoma in central retinal vein occlusion with vitreous hemorrhage
Stappler et al. Inverted internal limiting membrane flap technique for macular hole coexistent with rhegmatogenous retinal detachment
Tandias et al. Posterior vitreous detachment status as a predictive factor for outcomes of vitrectomy for diabetic vitreous hemorrhage
Siddiqui et al. Effect of cataract extraction on SITA perimetry in patients with glaucoma
Salam et al. Retinal tears and retinal detachment as factors affecting visual outcome after cataract extraction complicated by posteriorly dislocated lens material
Wickens et al. Outcomes of macular hole surgery and shortened face down positioning
Kumagai et al. Long-term visual outcomes after vitrectomy for macular edema with foveal hemorrhage in branch retinal vein occlusion
Banaee et al. Peripheral 360 retinectomy in complex retinal detachment
Singh et al. Bilateral simultaneous rhegmatogenous retinal detachment: clinical characteristics and surgical outcome
Oellers et al. Small-gauge valved versus nonvalved cannula pars plana vitrectomy for retinal detachment repair
Bansal et al. Outcome of pars plana vitrectomy in patients with retinal detachments secondary to retinal vasculitis
Huang et al. Changes in retinal sensitivity following inverted internal limiting membrane flap technique for large macular holes